GPT and metabolic dysfunction-associated steatotic liver disease: Consistent with the results of this study, Gheibi et al. showed that the co-administration of CUR (200 mg/kg) and UDCA (80 mg/kg) reduced ALT and AST levels in rats with non-alcoholic fatty liver disease.